4.7 Review

The Expression of Non-Coding RNAs and Their Target Molecules in Rheumatoid Arthritis: A Molecular Basis for Rheumatoid Pathogenesis and Its Potential Clinical Applications

期刊

出版社

MDPI
DOI: 10.3390/ijms22115689

关键词

rheumatoid arthritis; non-coding RNA; fibroblast-like synoviocyte; anti-citrullinated protein antibody; peptidylarginine deiminase; bone-marrow-derived stem cell; RANK-RANKL-OPG signaling; Wnt/beta-catenin pathway

资金

  1. Taipei Veterans General Hospital [V110C-046]
  2. Ministry of Science & Technology, Executive Yuan, Taiwan [107-2314-B-075-051-MY3]

向作者/读者索取更多资源

Rheumatoid arthritis is a typical autoimmune disease characterized by chronic synovitis in the joints, triggered by the production of autoantibodies through interactions among immune cells. Aberrant gene mutations, epigenetic regulation, and non-coding RNA expression are closely linked to the development of the disease.
Rheumatoid arthritis (RA) is a typical autoimmune-mediated rheumatic disease presenting as a chronic synovitis in the joint. The chronic synovial inflammation is characterized by hypervascularity and extravasation of various immune-related cells to form lymphoid aggregates where an intimate cross-talk among innate and adaptive immune cells takes place. These interactions facilitate production of abundant proinflammatory cytokines, chemokines and growth factors for the proliferation/maturation/differentiation of B lymphocytes to become plasma cells. Finally, the autoantibodies against denatured immunoglobulin G (rheumatoid factors), EB virus nuclear antigens (EBNAs) and citrullinated protein (ACPAs) are produced to trigger the development of RA. Furthermore, it is documented that gene mutations, abnormal epigenetic regulation of peptidylarginine deiminase genes 2 and 4 (PADI2 and PADI4), and thereby the induced autoantibodies against PAD2 and PAD4 are implicated in ACPA production in RA patients. The aberrant expressions of non-coding RNAs (ncRNAs) including microRNAs (miRs) and long non-coding RNAs (lncRNAs) in the immune system undoubtedly derange the mRNA expressions of cytokines/chemokines/growth factors. In the present review, we will discuss in detail the expression of these ncRNAs and their target molecules participating in developing RA, and the potential biomarkers for the disease, its diagnosis, cardiovascular complications and therapeutic response. Finally, we propose some prospective investigations for unraveling the conundrums of rheumatoid pathogenesis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据